Research Article
The Novel Diagnostic Biomarkers for Focal Segmental Glomerulosclerosis
Table 1
Demographic and laboratory characteristics of patients with focal segmental glomerulosclerosis and IgA nephropathy.
| Patient’s code | Age (yr) | Sex | eGFR (cc/min/1.73 m2) | Proteinuria (mg/day) | TA/IF | Disease |
| 1 | 29 | M | 34.61 | 2031 | <10% | FSGS | 2 | 46 | M | 34.64 | 5000 | 30% | FSGS | 3 | 19 | M | 145.76 | 4500 | 30% | FSGS | 4 | 61 | M | 46.52 | 2590 | <10% | FSGS | 5 | 37 | F | 78.51 | 1400 | <10% | FSGS | 6 | 36 | F | 60.52 | 2710 | 20% | FSGS | 7 | 37 | F | 42.01 | 710 | 30% | FSGS | 8 | 30 | M | 38.76 | 2925 | 40% | FSGS | 9 | 58 | F | 70.48 | 4373 | <10% | FSGS | 10 | 18 | M | 85.17 | 11000 | <10% | FSGS | 11 | 29 | M | 73.73 | 7000 | 10% | FSGS | 12 | 29 | M | 8.58 | 6000 | 80% | IgAN | 13 | 42 | M | 79.52 | 6420 | 10% | IgAN | 14 | 29 | M | 15.57 | 7020 | 80% | IgAN | 15 | 28 | M | 16.11 | 2330 | 80% | IgAN | 16 | 23 | F | 63.65 | 800 | 20% | IgAN | 17 | 34 | M | 97.76 | 1310 | 10% | IgAN |
|
|